Literature DB >> 30634002

Proteomic characterization of outer membrane vesicles from gut mucosa-derived fusobacterium nucleatum.

Jinjing Liu1, Ching-Lin Hsieh1, Ozkan Gelincik2, Bryan Devolder2, Shizuko Sei3, Sheng Zhang4, Steven M Lipkin5, Yung-Fu Chang6.   

Abstract

Fusobacterium nucleatum is a Gram-negative bacterium commonly found in the oral cavity and is often involved in periodontal diseases. Recent studies have shown increased F. nucleatum prevalence in colorectal cancer (CRC) tissues, and causal data has linked this bacterium to CRC tumorigenesis. Immune-based approaches to contain, reduce or eradicate its gut colonization may prevent CRC. Outer membrane vesicles (OMVs) are naturally produced by Gram-negative bacteria, typically contain multiple putative virulence factors and may elicit protective immune responses if used as vaccines. Here, OMVs were isolated from F. nucleatum cultures and purified using gradient centrifugation. Proteins contained within the OMVs were identified by nano LC/MS/MS analysis. Of 98 proteins consistently identified from duplicate analyses, 60 were predicted to localize to the outer membrane or periplasm via signal peptide driven translocation. Of these, six autotransporter proteins, which constitute the majority of protein mass of OMVs, were associated with Type V secretion system. In addition, other putative virulence factor proteins with functional domains, including FadA, MORN2 and YadA-like domain, were identified with multiple exposed epitope sites as determined by in silico analysis. Altogether, the non-replicative OMVs of F. nucleatum contain multiple antigenic virulence factors that may play important roles in the design and development of vaccines against F. nucleatum. SIGNIFICANCE: Fusobacterium nulceatum has been proved playing significant role in colorectal carcinogenesis. Outer membrane vesicles are nanoparticles that naturally secreted by Gram-negative bacterial containing various antigenic components, which provides new insight in vaccine development. Understanding the constituents of F. nucleatum OMVs will provide fundamental information and potential strategies for OMV-based F. nucleatum vaccines design. Based on our knowledge this is the first proteomic study of OMVs from F. nucleatum.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Fusobacterium nucleatum; Outer membrane vesicles; Proteomics

Mesh:

Substances:

Year:  2019        PMID: 30634002     DOI: 10.1016/j.jprot.2018.12.029

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  15 in total

1.  Utilizing Whole Fusobacterium Genomes To Identify, Correct, and Characterize Potential Virulence Protein Families.

Authors:  Ariana Umaña; Blake E Sanders; Christopher C Yoo; Michael A Casasanta; Barath Udayasuryan; Scott S Verbridge; Daniel J Slade
Journal:  J Bacteriol       Date:  2019-11-05       Impact factor: 3.490

2.  Extracellular vesicles of Fusobacterium nucleatum compromise intestinal barrier through targeting RIPK1-mediated cell death pathway.

Authors:  Le Liu; Liping Liang; Chenghai Yang; Youlian Zhou; Ye Chen
Journal:  Gut Microbes       Date:  2021 Jan-Dec

Review 3.  Proteome Analysis of Molecular Events in Oral Pathogenesis and Virus: A Review with a Particular Focus on Periodontitis.

Authors:  Sachio Tsuchida
Journal:  Int J Mol Sci       Date:  2020-07-22       Impact factor: 5.923

Review 4.  The dysbiosis signature of Fusobacterium nucleatum in colorectal cancer-cause or consequences? A systematic review.

Authors:  Maryam Ranjbar; Rasoul Salehi; Shaghayegh Haghjooy Javanmard; Laleh Rafiee; Habibollah Faraji; Sima Jafarpor; Gordon A Ferns; Majid Ghayour-Mobarhan; Mostafa Manian; Reza Nedaeinia
Journal:  Cancer Cell Int       Date:  2021-04-06       Impact factor: 6.429

5.  Fusobacterium nucleatum Secretes Outer Membrane Vesicles and Promotes Intestinal Inflammation.

Authors:  Melinda A Engevik; Heather A Danhof; Wenly Ruan; Amy C Engevik; Alexandra L Chang-Graham; Kristen A Engevik; Zhongcheng Shi; Yanling Zhao; Colleen K Brand; Evan S Krystofiak; Susan Venable; Xinli Liu; Kendal D Hirschi; Joseph M Hyser; Jennifer K Spinler; Robert A Britton; James Versalovic
Journal:  mBio       Date:  2021-03-02       Impact factor: 7.867

6.  Siglec-7 Mediates Immunomodulation by Colorectal Cancer-Associated Fusobacterium nucleatum ssp. animalis.

Authors:  Dimitra Lamprinaki; Pilar Garcia-Vello; Roberta Marchetti; Charlotte Hellmich; Kelli A McCord; Kristian M Bowles; Matthew S Macauley; Alba Silipo; Cristina De Castro; Paul R Crocker; Nathalie Juge
Journal:  Front Immunol       Date:  2021-10-01       Impact factor: 7.561

Review 7.  More Than Just a Periodontal Pathogen -the Research Progress on Fusobacterium nucleatum.

Authors:  Yuanxin Chen; Zhijie Huang; Zhengming Tang; Yisheng Huang; Mingshu Huang; Hongyu Liu; Dirk Ziebolz; Gerhard Schmalz; Bo Jia; Jianjiang Zhao
Journal:  Front Cell Infect Microbiol       Date:  2022-02-03       Impact factor: 5.293

Review 8.  Looking into key bacterial proteins involved in gut dysbiosis.

Authors:  Xin-Yu Zeng; Ming Li
Journal:  World J Methodol       Date:  2021-07-20

9.  The role of Fusobacterium nucleatum in colorectal cancer: from carcinogenesis to clinical management.

Authors:  Chun-Hui Sun; Bin-Bin Li; Bo Wang; Jing Zhao; Xiao-Ying Zhang; Ting-Ting Li; Wen-Bing Li; Di Tang; Miao-Juan Qiu; Xin-Cheng Wang; Cheng-Ming Zhu; Zhi-Rong Qian
Journal:  Chronic Dis Transl Med       Date:  2019-10-01

10.  Growth rate alterations of human colorectal cancer cells by 157 gut bacteria.

Authors:  Rahwa Taddese; Daniel R Garza; Lilian N Ruiter; Marien I de Jonge; Clara Belzer; Steven Aalvink; Iris D Nagtegaal; Bas E Dutilh; Annemarie Boleij
Journal:  Gut Microbes       Date:  2020-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.